Trending News

Changes to Civil Rights Enforcement: New Executive Order Eliminates Disparate-Impact Liability in Federal Regulations

How Are Family Offices Building Smarter Wealth? Structural Alpha (11 Examples)

DOJ Rule Restricting Sensitive Data Transfers Takes Effect

The Trump Administration’s Diversity, Equity, and Inclusion (DEI) Executive Orders: A Brief Primer

Trump Administration Announces "Reciprocal" Tariffs

What Every Multinational Company Should Know About … The Global and Reciprocal Tariffs Announcement

Blockading the Ports: U.S. Imposes 10% Global Tariff; Higher Reciprocal Tariff Rates by Country

Fifth Circuit Court of Appeals Negates Ruling on Federal Contractor Minimum Wage

New Executive Order Rescinds the $17.75 Per Hour Federal Contractor Minimum Wage

Medicare Telehealth Gets Another Temporary Lifeline – Will Congress Make it Permanent?

GlobeNewswire Biotech

Website

www.globenewswire.com

Featured Biotech Press Releases From GlobeNewswire

Cyclacel Pharmaceuticals Announces $1 Million Private Placement Offering of Convertible Preferred Stock
Posted On Monday, March 24, 2025
Moleculin Reports Full Year 2024 Financial Results and Provides Corporate Update
Posted On Monday, March 24, 2025
Clearside Biomedical Announces Six Abstracts Accepted for Presentation at Association for Research in Vision and Ophthalmology (ARVO) 2025 Meeting
Posted On Monday, March 24, 2025
UNITY Biotechnology Announces Topline Results from the ASPIRE Phase 2b Study in Diabetic Macular Edema
Posted On Monday, March 24, 2025
Lexeo Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights
Posted On Monday, March 24, 2025
Entrada Therapeutics Receives Authorization in the United Kingdom to Initiate ELEVATE-45-201, a Phase 1/2 Multiple Ascending Dose Clinical Study of ENTR-601-45 in People Living with Duchenne Muscular Dystrophy Amenable to Exon 45 Skipping
Posted On Monday, March 24, 2025
Larimar Therapeutics Provides Nomlabofusp Development Update and Reports Fourth Quarter and Full Year 2024 Financial Results
Posted On Monday, March 24, 2025
Codexis Announces First Revenue-Generating Contract for ECO Synthesis™ Manufacturing Services
Posted On Monday, March 24, 2025
ProMIS Neurosciences Showcases Preclinical Data on Platform-Derived Antibody and Vaccines for Neurodegenerative Diseases at Alzheimer’s Disease/Parkinson’s Disease 2025 International Conference
Posted On Monday, March 24, 2025
Tilray Wellness Collaborates with Whole Foods Market to Relaunch Hi*Ball Energy Drinks into National US Retail
Posted On Monday, March 24, 2025
Elicio Therapeutics Appoints Preetam Shah, Ph.D., MBA, as Chief Strategy and Financial Officer
Posted On Monday, March 24, 2025
Dogecoin Cash, Inc. Subsidiary MEME Coins Inc. Acquires 1 Billion DOG Tokens from Tipestry, Inc.
Posted On Monday, March 24, 2025
Positive Data from Phase 1 Trial of Bel-sar in Patients with Non-Muscle-Invasive Bladder Cancer (NMIBC) Presented at the 40th Annual European Association of Urology Congress
Posted On Monday, March 24, 2025
Centessa Pharmaceuticals Reports Business Highlights and Financial Results for the Fourth Quarter and Full-Year 2024
Posted On Monday, March 24, 2025
Serina Therapeutics to Present at the American Chemistry Society (ACS) Spring 2025 Meeting
Posted On Monday, March 24, 2025
NativePath Native Hydrate: The Senior Hydration Solution That Supports Energy, Bladder Health & Brain Function
Posted On Monday, March 24, 2025
23andMe Initiates Voluntary Chapter 11 Process to Maximize Stakeholder Value Through Court-Supervised Sale Process
Posted On Sunday, March 23, 2025
UNITY Biotechnology to Host Virtual Investor Event to Discuss 24- and 36-Week Data from the Phase 2b ASPIRE Study of UBX1325 in Patients with Diabetic Macular Edema (DME) on March 24, 2025
Posted On Sunday, March 23, 2025
Arialief Reviews (Is It Safe And Legit To Use?) What Do Arialief Consumer Reports Say About Its Efficacy?
Posted On Saturday, March 22, 2025
Atea Pharmaceuticals Issues Statement Regarding Director Nominations
Posted On Friday, March 21, 2025
Annovis Provides Corporate Updates and Reports Fourth Quarter and Fiscal Year 2024 Financial Results
Posted On Friday, March 21, 2025
Restore Value Slate Led by Mina Sooch Files Preliminary Proxy Materials for the Election of Six Highly Qualified Directors at the 2025 Annual Meeting of Opus Genetics
Posted On Friday, March 21, 2025
Eagle Pharmaceuticals Announces Amendment to Limited Duration Stockholder Rights Plan
Posted On Friday, March 21, 2025
Immuneering Corporation Announces Grant of Inducement Award
Posted On Friday, March 21, 2025
I-Mab Announces Receipt Of Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement
Posted On Friday, March 21, 2025

Print